Synthesis, β-adrenergic blocking activity and β-receptor binding affinities of 1-substituted-3-(2-isopropyl-5-methyl-phenoxy)-propan-2-ol oxalates-Reference-Cited by-同舟云学术

Synthesis, β-adrenergic blocking activity and β-receptor binding affinities of 1-substituted-3-(2-isopropyl-5-methyl-phenoxy)-propan-2-ol oxalates

Published:2003-08 Issue:8 Volume:58 Page:557-562
ISSN:0014-827X
Container-title:Il Farmaco
language:en
Short-container-title:Il Farmaco

Author:

Jindal Dharam Paul,Coumar Mohane S,Nandakumar K,Bodhankar Subhash Laxmanrao,Purohit Prasad Gopal,Mahadik Kakasaheb Ramoo,Bruni Giancarlo,Collavoli Elga,Massarelli Paola

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmaceutical Science

Reference22 articles.

1. Antihypertensive drugs: Issues beyond blood pressure control;Pinkey;Prog. Cardiovasc. Dis.,1994

2. Progression from hypertension to heart failure;Cleland;Cardiology,1999

3. Current drug treatment and treatment patterns with antihypertensive drugs;Freis;Drugs,1996

4. Joint National Committee on Prevention, Detection, evaluation and treatment of high blood pressure. The sixth report, Arch. Intern. Med. 157 (1997) 2413–46.

5. Recent advances in β-adrenergic blocking agents;Main,1985

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymol Chemistry: A Medicinal Toolbox;Current Bioactive Compounds;2019-01-03

2. Novel thymol bearing oxypropanolamine derivatives as potent some metabolic enzyme inhibitors – Their antidiabetic, anticholinergic and antibacterial potentials;Bioorganic Chemistry;2018-12

3. Mechanism-Based Pharmacodynamic Modeling of S(–)-Atenolol: Estimation of in Vivo Affinity for the β1-Adrenoceptor with an Agonist-Antagonist Interaction Model;Journal of Pharmacology and Experimental Therapeutics;2007-12-27

4. β-Blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals;Journal of Pharmacy and Pharmacology;2007-03

5. Synthesis of 4-(1-oxo-isoindoline) and 4-(5,6-dimethoxy-1-oxo-isoindoline)-substituted phenoxypropanolamines and their β1-, β2-adrenergic receptor binding studies;Bioorganic Chemistry;2005-08